JP2022550901A5 - - Google Patents

Info

Publication number
JP2022550901A5
JP2022550901A5 JP2022520803A JP2022520803A JP2022550901A5 JP 2022550901 A5 JP2022550901 A5 JP 2022550901A5 JP 2022520803 A JP2022520803 A JP 2022520803A JP 2022520803 A JP2022520803 A JP 2022520803A JP 2022550901 A5 JP2022550901 A5 JP 2022550901A5
Authority
JP
Japan
Prior art keywords
seq
peptide
nucleic acid
sirna
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550901A (ja
JP7644105B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054251 external-priority patent/WO2021067930A1/en
Publication of JP2022550901A publication Critical patent/JP2022550901A/ja
Publication of JP2022550901A5 publication Critical patent/JP2022550901A5/ja
Application granted granted Critical
Publication of JP7644105B2 publication Critical patent/JP7644105B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520803A 2019-10-04 2020-10-05 核酸治療薬のための腫瘍標的化ポリペプチドナノ粒子送達システム Active JP7644105B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962910760P 2019-10-04 2019-10-04
US62/910,760 2019-10-04
US201962915450P 2019-10-15 2019-10-15
US62/915,450 2019-10-15
PCT/US2020/054251 WO2021067930A1 (en) 2019-10-04 2020-10-05 Tumor-targeting polypeptide nanoparticle delivery system for nucleic acid therapeutics

Publications (3)

Publication Number Publication Date
JP2022550901A JP2022550901A (ja) 2022-12-05
JP2022550901A5 true JP2022550901A5 (cg-RX-API-DMAC7.html) 2023-10-16
JP7644105B2 JP7644105B2 (ja) 2025-03-11

Family

ID=75337467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520803A Active JP7644105B2 (ja) 2019-10-04 2020-10-05 核酸治療薬のための腫瘍標的化ポリペプチドナノ粒子送達システム

Country Status (11)

Country Link
US (1) US20220331441A1 (cg-RX-API-DMAC7.html)
EP (1) EP4037716A4 (cg-RX-API-DMAC7.html)
JP (1) JP7644105B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220110174A (cg-RX-API-DMAC7.html)
CN (1) CN115151278B (cg-RX-API-DMAC7.html)
AU (1) AU2020357078A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022006473A2 (cg-RX-API-DMAC7.html)
CA (1) CA3156823A1 (cg-RX-API-DMAC7.html)
IL (1) IL291916A (cg-RX-API-DMAC7.html)
WO (1) WO2021067930A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202204734B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7512207B2 (ja) * 2018-05-24 2024-07-08 サーナオミクス インコーポレイテッド 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法
CN118613484A (zh) * 2021-12-30 2024-09-06 拜奥迪斯私人有限公司 抗叶酸剂接头-药物和抗体-药物缀合物
CN120158469A (zh) * 2025-05-19 2025-06-17 内蒙古大学 一种灌胃递送靶向编辑甲烷八叠球菌的牛甲烷减排方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10501963A (ja) * 1994-04-15 1998-02-24 ターゲテッド ジェネティクス コーポレイション 遺伝子送達融合タンパク質
EP1817416A2 (en) * 2004-11-05 2007-08-15 Intradigm Corporation Compositions for treating respiratory viral infections and their use
EP1812016A4 (en) * 2004-11-17 2010-07-14 Univ Maryland HIGH-BRANCHED HK-PEPTIDES AS EFFECTIVE CARRIER FROM SIRNA
ES2545963T3 (es) * 2007-11-06 2015-09-17 Sirnaomics, Inc. Terapéutica con ARNi multidirigidos para la cicatrización de heridas de la piel sin cicatriz
CN102316858A (zh) * 2008-02-26 2012-01-11 阿帕玛生物科技公司 修饰过的可调的纳米粒子用于传递治疗,诊断,实验化合物及相关成分用于治疗用药
WO2010078517A2 (en) 2008-12-31 2010-07-08 Sirnaomics, Inc. Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer
WO2011011631A2 (en) * 2009-07-22 2011-01-27 Samuel Zalipsky Nucleic acid delivery vehicles
US11058779B2 (en) * 2015-09-08 2021-07-13 Sirnaomics, Inc. Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
CN107793388B (zh) * 2016-10-14 2021-06-11 长沙天赐生物医药科技有限公司 平板霉素类似物及其制备方法和应用
EP3532071A4 (en) * 2016-10-30 2020-09-02 Sirnaomics, Inc. PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE TO ACTIVATE HUMAN FIBROBLAST AND MYOFIBROBLAST APOPTOSIS
JP7512207B2 (ja) 2018-05-24 2024-07-08 サーナオミクス インコーポレイテッド 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法
US20210180089A1 (en) * 2018-08-14 2021-06-17 Loxegen Holdings Pty Ltd Nanoparticles for transfection
WO2021061437A1 (en) 2019-09-12 2021-04-01 Sirnaomics, Inc. CO-DELIVERY OF TGF-β SIRNA AND PDL1 SIRNA TO TREAT CANCER

Similar Documents

Publication Publication Date Title
Gooding et al. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis
CN112370532B (zh) 作为转染试剂的羧化多胺衍生物
Uritu et al. Hybrid fullerene conjugates as vectors for DNA cell-delivery
EP1981543A1 (en) Chemically modified polycation polymer for sirna delivery
JP7708728B2 (ja) カチオン性粘液酸ポリマー系デリバリーシステム
EP2903652A1 (en) Hydroxylated polyamine derivatives as transfection reagents
US20220331441A1 (en) Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics
US12054714B2 (en) Peptide docking vehicle for targeted nucleic acid delivery
CN115244064A (zh) 治疗性分子的靶向递送
CN111218443B (zh) 合成核酸药物偶联物的方法
CN106397765A (zh) 维生素e修饰的聚乙烯亚胺衍生物及其合成方法和应用
JP2003503569A (ja) 核酸を細胞に輸送するためのコポリマー
WO2008048079A1 (en) Long acting formulation of biopharmaceutical
EP3507309B1 (en) Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular polymer, and cyclodextrin si-rna complex and method of synthesis thereof
KR102823910B1 (ko) 바이오 약물의 경구전달용 덴드리머 구조 흡수 증진제
US20250263694A1 (en) Conjugated composition and method for delivering a therapeutic nucleic acid sequence to a living cell
WO2025238236A1 (en) Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol
KR100346577B1 (ko) 간세포 특이적인 담체 및 이의 dna와의 복합체
Deng et al. MC8 peptide-mediated Her-2 receptor targeting based on PEI-β-CyD as gene delivery vector
KR20250028446A (ko) 세포내 전달을 위한 펩타이드
US20100261245A1 (en) Long acting formulation of biopharmaceutical
KR20240099391A (ko) 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 표적화된 선형의 컨쥬게이트 및 이를 포함하는 다중복합체
WO2026016810A1 (zh) 抗体寡核苷酸缀合物及其用途
Simpson Synthesis, Characterization, and Assessment of Cationic Polypeptoids Toward Gene Delivery and Development of Air Stable N-Substituted N-Thiocarboxyanhydrides
Baumhover The synthesis and development of novel multi-component polyacridine gene delivery systems